Statute Details
- Title: National Registry of Diseases Act 2007
- Act Code: NRDA2007
- Full Title: An Act to establish the National Registry of Diseases and to provide for the compilation of information on the incidence of certain diseases for use as a basis for the direction of programmes for disease prevention and control, and for purposes connected therewith.
- Type: Act of Parliament
- Status / Current Version: Current version as at 27 Mar 2026 (per provided extract)
- Key Structure: Part 1 (Preliminary); Part 2 (National Registry of Diseases); Part 3 (Notification of reportable diseases); Part 4 (Confidentiality and disclosure); Part 5 (Enforcement powers); Part 6 (Miscellaneous)
- Principal Actors: Director-General of Health; Registrar of the Registry; Registry officers; investigation officers
- Core Mechanism: Mandatory notification of “reportable diseases” and regulated handling of disease incidence information
- Schedule: Lists “reportable diseases”
- Notable Related Instruments (as provided): Diseases Act 2007; Diseases Act 2007 (contextual reference); Healthcare Services Act 2020; Medical Registration Act 1997
What Is This Legislation About?
The National Registry of Diseases Act 2007 (the “Act”) establishes Singapore’s National Registry of Diseases (the “Registry”). In plain terms, it creates a legal framework for collecting and maintaining information about the incidence of certain diseases so that public health authorities can plan, direct, and evaluate disease prevention and control programmes.
The Act is not simply an administrative record-keeping statute. It creates a structured system that (i) identifies which diseases must be reported (through the Schedule of “reportable diseases”), (ii) imposes a duty to notify the Registrar, and (iii) governs how information may be collected, stored, anonymised, disclosed, and used—particularly where disclosure involves individually-identifiable information.
Because disease reporting inevitably touches on sensitive personal data, the Act also builds in confidentiality protections and carefully controlled disclosure pathways. It further provides enforcement powers (including entry, inspection, search, and seizure) to ensure compliance, and it creates offences and related procedural mechanisms.
What Are the Key Provisions?
1. Establishment and governance of the Registry (Parts 1 and 2). The Act begins with standard preliminary provisions on short title and interpretation. It then provides for the appointment of the Registrar (and related officers) by the Director-General of Health. The Registrar is responsible for establishing and maintaining the Registry and for keeping “registers” under the Act. These registers form the backbone for storing disease incidence information and supporting downstream public health planning.
2. Mandatory notification of reportable diseases (Part 3). The central operational obligation is contained in the duty to notify the Registrar of “reportable diseases.” A “reportable disease” is defined as a disease specified in the Schedule. Practically, this means that once a disease is listed, healthcare providers and relevant persons must notify the Registry in accordance with the Act and any applicable regulations or prescribed requirements.
The Act also addresses collection of information. This is important for practitioners because it signals that notification is not limited to a bare minimum. The Registry is empowered to collect information necessary to compile incidence data. The scope of what must be provided is typically operationalised through regulations and prescribed forms/methods, but the Act’s structure makes clear that the information is intended to support epidemiological analysis and programme direction.
3. Confidentiality and controlled disclosure (Part 4). Part 4 is the privacy and governance core. Section 8 provides for confidentiality—meaning that information held by the Registry is protected and cannot be freely disclosed. The Act then distinguishes between disclosure of anonymised information and disclosure of individually-identifiable information.
Section 9 provides for disclosure and publication of anonymised information. “Anonymised” is defined to mean that an individual’s identity has been concealed or protected such that it cannot be readily discovered or ascertained from the information. This supports public health transparency (e.g., aggregated statistics) while reducing privacy risk.
Section 10 addresses national public health programmes, indicating that the Registry’s information may be used to support programme planning and implementation. Section 11 deals with medical treatment, signalling that certain disclosures may be permitted where they are connected to patient care (subject to the Act’s conditions).
Section 12 is particularly significant for lawyers: it permits disclosure of individually-identifiable information for public health research, but only under strict conditions. The Act introduces the concept of “requisite consent”—either the consent of the person whose individually-identifiable information is to be disclosed, or (where the person cannot give consent due to age, infirmity of mind or body, or other causes) consent by an authorised person under the regulations. This consent framework is designed to balance research utility with individual privacy rights.
4. Enforcement powers and compliance (Part 5). To ensure that notification and information-handling obligations are met, Part 5 provides for enforcement. Section 13 allows for the appointment of investigation officers. Sections 14 and 15 provide robust powers, including powers of entry, inspection, search, seizure, and powers to examine and secure attendance. For practitioners, this is a key risk area: non-compliance is not merely a paper violation; the Act contemplates active investigation and evidence-gathering.
How Is This Legislation Structured?
The Act is organised into six Parts, moving from foundational definitions to operational duties, privacy controls, enforcement, and miscellaneous provisions.
Part 1 (Preliminary) contains the short title and interpretation provisions, including definitions that clarify key terms such as “disease,” “reportable disease,” “anonymised,” and “individually-identifiable.” It also defines roles such as “Registrar,” “Registry officer,” and “investigation officer.”
Part 2 (National Registry of Diseases) sets up the Registry’s governance: appointment of the Registrar and the establishment of the Registry and registers.
Part 3 (Notification of reportable diseases) creates the duty to notify and authorises collection of information.
Part 4 (Confidentiality and disclosure) sets out the confidentiality obligation and the permitted pathways for disclosure, including anonymised publication, use for public health programmes, medical treatment, and research involving individually-identifiable information (subject to consent).
Part 5 (Enforcement powers) provides investigation and coercive powers to ensure compliance.
Part 6 (Miscellaneous) includes offences by bodies corporate, protection from liability, offences relating to obstructing the Registrar/Registry officers, jurisdiction of court, composition of offences, general exemption, amendment of the Schedule, regulation-making powers, and a saving provision for personal information previously collected.
Who Does This Legislation Apply To?
The Act applies primarily to the Registry and the persons who have duties connected to notification and information handling. While the provided extract does not list every category of obligated person in the notification section, the definitions and enforcement framework indicate that the duty to notify is directed at healthcare-related actors involved in diagnosing, treating, or managing patients with reportable diseases.
In addition, the Act applies to public officers and Registry officers who handle Registry information, because confidentiality and disclosure restrictions bind those who access or process information. Where disclosure for research involves individually-identifiable information, the Act also affects researchers and institutions receiving such information, because disclosure is conditioned on the consent framework (“requisite consent”) and the statutory purpose (public health research).
Why Is This Legislation Important?
The Act is important because it operationalises a core public health function: turning clinical events into incidence data that can guide prevention and control programmes. From a practitioner’s perspective, the legal significance lies in the combination of (i) mandatory reporting duties for specified diseases and (ii) a regulated regime for privacy-protective handling of the resulting information.
For healthcare providers and compliance teams, the Act creates a compliance obligation tied to the Schedule of reportable diseases. Because the Schedule can be amended (see section 22), organisations must monitor updates to ensure that their internal reporting processes remain aligned with current legal requirements.
For privacy and research stakeholders, Part 4 is the key. The Act’s distinction between anonymised information and individually-identifiable information is not merely conceptual—it drives what can be disclosed, to whom, and under what conditions. The “requisite consent” requirement for individually-identifiable public health research is a practical compliance checkpoint for ethics, governance, and data-sharing arrangements.
Finally, the enforcement powers in Part 5 underscore that the State can investigate and compel information-gathering. This elevates the importance of maintaining accurate notification records, ensuring staff understand reporting triggers, and ensuring that any disclosures are authorised and documented in line with the Act.
Related Legislation
- Diseases Act 2007
- Healthcare Services Act 2020 (including definitions relevant to “healthcare institution” and related concepts)
- Medical Registration Act 1997 (relevant to the definition of “medical practitioner”)
Source Documents
This article provides an overview of the National Registry of Diseases Act 2007 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.